21 Jul 2018 | 1:17 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
768.65
7.30
(0.96 %)
20 Jul 2018 | 03:54 PM
Change company
  • Open (Rs)
    774.80
  • Prev. close (Rs.)
    761.35
  • High (Rs.)
    774.90
  • Low (Rs.)
    760.00
  • 52W H (Rs.)
    1,061.95
  • 52W L (Rs.)
    671.25
  • Volume
    5666
  • MCap (Rs in Cr.)
    14,181.06
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
27.88
Operating Margin (%)
33.82
Gross Profit Margin (%)
31.13
Net Profit Margin (%)
24.05
Total Debt/Equity
0.13
Dividend payout Ratio (Net Profit)
29.13
Earning Retention Ratio
70.80

News

02 Jul 2018 - 13:50:00-Natco Pharma today said it has launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for...
11 Jun 2018 - 00:01:00-Natco Pharma Limited has said that it has launched a generic version of Posaconazole Inject...
23 May 2018 - 16:10:00-The company reported standalone net profit of Rs 296...
05 Apr 2018 - 09:23:00-Leading pharma major Natco Pharma Limited has said that it is the first company in India to launch a...

Announcements

05-Jul-2018
Natco Pharma - Shareholding for the Period Ended June 30 2018
02-Jul-2018
Natco Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
02-Jul-2018
Natco Pharma - Press Release
08-Jun-2018
Natco Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
08-Jun-2018
Natco Pharma - Press Release

Religare Research

20 Jul 2018 | 07:00 PM
Nifty ended almost unchanged in the volatile passing week, taking a breather after the recent rise.
20 Jul 2018 | 07:00 PM
Incorporated in 1986, Power Finance Corporation Ltd. (PFC) is a Schedule-A Navratna CPSE, and is one...
20 Jul 2018 | 11:13 AM
Highlights: • Agri markets kept trading with high volatility as improved Monsoon activities – mai...
20 Jul 2018 | 10:20 AM
DTF

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 29.70 0.54
4,00,000 90.05 143.48 0.54
4,00,000 90.05 151.50 0.54
4,00,000 90.05 50.87 0.55
1,60,000 35.89 69.65 0.76

Shareholding Pattern

       
Promotors48.38%
Mutual Funds/UTI5.37%
FI/Banks0.89%
Insurance0.89%
FII24.39%
Government0.00%
Others3.78%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,300.50(0.35)
3280
 Sanofi India Ltd.
5,491.90(-0.25)
3325
 GlaxoSmithKline Pharmaceuticals Ltd.
2,775.00(0.41)
3317
 Pfizer Ltd.
2,524.50(-1.03)
3370

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.-53.80-32.75-239.40
NIFTY(S&P CNX)238.15446.1544.00
BSE SENSEX949.042,080.79698.36
BSE 50020.31-82.50-748.03

Corporate Details

Key Personal
A K S Bhujanga Rao
Director & President (R&D and Tech.)
A K S Bhujanga Rao
President & Director
D Linga Rao
Director & President (Tech. Affairs)
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :12-10-134 (MIG 134) 2nd Floor Bharatnagar Colony